01273 704473

info@novuscomms.com

01273 704473

info@novuscomms.com

Venture Life Group #VLG publishes trading update & reports FY profits ahead of market expectations February 1, 2021 – Posted in: Blog, Venture Life Group (VLG)

Venture Life (AIM: VLG), a leader in developing, manufacturing and commercialising products for the self-care market, announces its unaudited trading update for the year ended 31st December 2020, ahead of the announcement of the Group’s audited results on 25th March 2021. The Company expects to report revenues for the year ended 31st December 2020 of £30.1 million, 49% higher than for 2019, and adjusted* EBITDA is expected to be not less than £6 million, more…

Continue reading

(No title) November 16, 2020 – Posted in: Venture Life Group (VLG)

16th November, 2020 VENTURE LIFE GROUP PLC (“Venture Life” “VLG” or the “Company”) Cardiff University’s published in-vitro study reports two CPC-based mouthwashes completely eradicate SARS-CoV-2 (COVID-19) within a 30 second exposure Venture Life (AIM: VLG), a leader in developing, manufacturing and commercialising products for the self-care market, announced on 24 August 2020 its involvement in a UK-led clinical trial, with one of its key oral care brands containing the powerful Cetylpyridinium Chloride (“CPC”) technology, on those affected with COVID-19.…

Continue reading

Venture Life Group #VLG – CEO Jerry Randall discusses today’s interim results & trading update September 24, 2020 – Posted in: Venture Life Group (VLG)

Alan Green talks to Venture Life Group (VLG) CEO Jerry Randall about the company’s interim results. Jerry goes through the numbers and commercial developments for the period, before discussing post period-end developments, including an independent study at Cardiff University on the effects on Dentyl Dual Action mouthwash on patients affected by COVID-19. Jerry explains the resilience and adaptability of the Venture Life business model in countering the challenge of the COVID lockdown, and highlights how…

Continue reading